Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trial

BACKGROUND: Dual antiplatelet therapy (DAPT) with aspirin (ASP) and a P2Y(12) blocker is currently standard care after percutaneous coronary intervention (PCI) with stent insertion, and aims to inhibit platelet function in order to prevent stent thrombosis. The P2Y(12) blocker ticagrelor (TIC) has g...

Descripción completa

Detalles Bibliográficos
Autores principales: Baos, Sarah, Underwood, Wendy, Culliford, Lucy, Reeves, Barnaby C., Rogers, Chris A., Bowles, Ruth, Johnson, Tom, Baumbach, Andreas, Mumford, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680755/
https://www.ncbi.nlm.nih.gov/pubmed/29121979
http://dx.doi.org/10.1186/s13063-017-2277-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680755/
https://www.ncbi.nlm.nih.gov/pubmed/29121979
http://dx.doi.org/10.1186/s13063-017-2277-9

Ejemplares similares